Authors:
Cao, TM
Horning, SF
Negrin, RS
Hu, WW
Johnston, LF
Taylor, TL
Shizuru, JA
Hoppe, RT
Brown, BW
Blume, KG
Stockerl-Goldstein, K
Citation: Tm. Cao et al., High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience, BIOL BLOOD, 7(5), 2001, pp. 294-301
Authors:
Verneris, MR
Ito, M
Baker, E
Arshi, A
Negrin, RS
Shizuru, JA
Citation: Mr. Verneris et al., Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma, BIOL BLOOD, 7(10), 2001, pp. 532-542
Authors:
Stuart, MJ
Chao, NS
Horning, SJ
Wong, RM
Negrin, RS
Johnston, LJ
Shizuru, JA
Long, GD
Blume, KG
Stockerl-Goldstein, KE
Goldstein, S
Citation: Mj. Stuart et al., Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease, BIOL BLOOD, 7(10), 2001, pp. 552-560
Authors:
McSweeney, PA
Niederwieser, D
Shizuru, JA
Sandmaier, BM
Molina, AJ
Maloney, DG
Chauncey, TR
Gooley, TA
Hegenbart, U
Nash, RA
Radich, J
Wagner, JL
Minor, S
Appelbaum, FR
Bensinger, WI
Bryant, E
Flowers, MED
Georges, GE
Grumet, FC
Kiem, HP
Torok-Storb, B
Yu, G
Blume, KG
Storb, RF
Citation: Pa. Mcsweeney et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, BLOOD, 97(11), 2001, pp. 3390-3400
Authors:
Baker, J
Verneris, MR
Ito, M
Shizuru, JA
Negrin, RS
Citation: J. Baker et al., Expansion of cytolytic CD8(+) natural killer T cells with limited capacityfor graft-versus-host disease induction due to interferon gamma production, BLOOD, 97(10), 2001, pp. 2923-2931
Authors:
Cao, TM
Negrin, RS
Stockerl-Goldstein, KE
Johnston, LJ
Shizuru, JA
Taylor, TL
Rizk, NW
Wong, RM
Blume, KG
Hu, WW
Citation: Tm. Cao et al., Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation, BIOL BLOOD, 6(4), 2000, pp. 387-394
Authors:
Negrin, RS
Atkinson, K
Leemhuis, T
Hanania, E
Juttner, C
Tierney, K
Hu, WW
Johnston, LJ
Shizuru, JA
Stockerl-Goldstein, KE
Blume, KG
Weissman, IL
Bower, S
Baynes, R
Dansey, R
Karanes, C
Peters, W
Klein, J
Citation: Rs. Negrin et al., Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer, BIOL BLOOD, 6(3), 2000, pp. 262-271
Authors:
Hu, WW
Negrin, RS
Stockerl-Goldstein, K
Johnston, LJ
Shizuru, JA
Wong, RM
Chao, NJ
Long, GD
Feiner, RH
Blume, KG
Citation: Ww. Hu et al., Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy, BIOL BLOOD, 6(1), 2000, pp. 58-69
Authors:
Shizuru, JA
Weissman, IL
Kernoff, R
Masek, M
Scheffold, YC
Citation: Ja. Shizuru et al., Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection, P NAS US, 97(17), 2000, pp. 9555-9560